NCT00258856View on ClinicalTrials.gov

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

PHASE2CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

November 30, 2007

Conditions
MeningitisMeningococcal Infection
Interventions
BIOLOGICAL

Polysaccharide Diphtheria Conjugate Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Polysaccharide Diphtheria Conjugate Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Polysaccharide Diphtheria Conjugate Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Polysaccharide Diphtheria Conjugate Vaccine

0.5 mL, Intramuscular

Trial Locations (11)

14620

Rochester

15241

Pittsburgh

18960

Sellersville

23510

Norfolk

30062

Marietta

63044

Bridgeton

72205

Little Rock

72401

Jonesboro

84123

Salt Lake City

21201-1559

Baltimore

01801

Woburn

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00258856 - Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune® | Biotech Hunter | Biotech Hunter